Vaccine Law and Policy

Yang, Y. Tony, Reiss, Dorit R.

Vaccine Law and Policy
  • 出版商: Springer
  • 出版日期: 2024-08-25
  • 售價: $3,010
  • 貴賓價: 9.5 折 $2,860
  • 語言: 英文
  • 頁數: 230
  • 裝訂: Quality Paper - also called trade paper
  • ISBN: 3031369912
  • ISBN-13: 9783031369919

    • 海外代購書籍(需單獨結帳)

相關主題

商品描述

Vaccine Law and Policy is the first book on vaccine law and policy written specifically for the general public or an educated lay audience without legal background. It offers comprehensive but accessible coverage of key aspects of vaccine law and policy, from product development and intellectual property protections, to regulation, public mandates, and vaccine injury claims. The COVID-19 pandemic sparked a growing interest in learning more about vaccine law and policy, as vaccine development, access, safety and requirements became relevant to hundreds of millions of people worldwide. This book covers United States law in most detail, but the developments and trends described have parallels in many countries, and the United States model and its actions influence others. Some of the most widely used vaccines against COVID-19 - mRNA vaccines - were developed in the United States, and choices made in the United States impact other countries.

United States law currently has so much to say about vaccines. From the federal mandate President Biden enacted requiring federal employees to be vaccinated against COVID-19, to the growing number of private employers requiring vaccines to return to work, vaccine law has become a prevalent topic in everyday life. But there is little writing about the legal aspects of vaccines directed at the general public or an educated lay audience without a legal background. Vaccine Law and Policy will not only be invaluable to professionals implementing vaccine law and policy, but also to regulators, public health officials, and scientific researchers.

Vaccine Law and Policy covers the wide range of laws and policies that impact the field. These include, among others, regulatory oversight by the FDA, one of the most influential bodies in drug and vaccines regulation worldwide, enforcement, and regulation of the research and development of vaccines; vaccine mandates for children and in the workplace, and medical, religious, and philosophical exemptions to them; patent law and other intellectual property protections such as trademark, trade secret, unfair competition, and copyright law; compensation for vaccine injuries under the National Vaccine Injury Compensation Program (NVICP) and other avenues of liability; safety monitoring; access to vaccines, their promotion, and issues related to funding and costs. The book will also discuss issues related to anti-vaccine movements and vaccine advocacy.

商品描述(中文翻譯)

《疫苗法與政策》是第一本專為一般大眾或沒有法律背景的受過教育的讀者撰寫的疫苗法與政策書籍。它提供了對疫苗法與政策關鍵方面的全面但易於理解的介紹，涵蓋了從產品開發和智慧財產權保護，到監管、公眾要求和疫苗傷害索賠等各個層面。隨著 COVID-19 疫情的爆發，越來越多的人對疫苗法與政策產生了興趣，因為疫苗的開發、獲取、安全性和要求變得與全球數億人息息相關。本書詳細介紹了美國的法律，但所描述的發展和趨勢在許多國家都有相似之處，而美國的模式及其行動也影響著其他國家。一些最廣泛使用的 COVID-19 疫苗——mRNA 疫苗——是在美國開發的，而美國所做的選擇對其他國家產生影響。

美國法律目前對疫苗有很多規定。從拜登總統頒布的要求聯邦員工接種 COVID-19 疫苗的聯邦命令，到越來越多的私人雇主要求員工接種疫苗才能返回工作，疫苗法已成為日常生活中的熱門話題。然而，針對一般大眾或沒有法律背景的受過教育的讀者，關於疫苗法律方面的著作卻寥寥無幾。《疫苗法與政策》不僅對實施疫苗法與政策的專業人士具有重要價值，對監管機構、公衛官員和科學研究人員也同樣重要。

《疫苗法與政策》涵蓋了影響該領域的各種法律和政策。其中包括 FDA 的監管，這是全球藥物和疫苗監管中最具影響力的機構之一，執法和疫苗研究與開發的監管；針對兒童和工作場所的疫苗要求，以及對這些要求的醫療、宗教和哲學豁免；專利法和其他智慧財產權保護，如商標、商業秘密、不正當競爭和著作權法；根據國家疫苗傷害賠償計劃 (NVICP) 和其他責任途徑對疫苗傷害的賠償；安全監測；疫苗的獲取、推廣以及與資金和成本相關的問題。本書還將討論與反疫苗運動和疫苗倡導相關的議題。

作者簡介

Y. Tony Yang, ScD, LLM, MPH, is an endowed Professor of Health Policy (with tenure) at the George Washington University in the Washington, D.C. His main scholarly interest is in policy issues at the intersection of the legal and health systems, especially in vaccination policy. He takes an empirical approach to most of his research, blending methods from the econometrical and statistical sciences with more traditional legal research methods. He has authored more than 150 peer-reviewed articles. His first-authored work has appeared in leading journals, including NEJM, JAMA, Lancet, Health Affairs, and American Journal of Public Health. The impact of his scholarship is observable in media coverage such as CNN, NPR, NY Times, Washington Post, and Wall Street Journal. He has been awarded more than $5.5 million U.S. federal grants as principal investigator. Also, he has been supported by various foundation funders as principal investigator, including Robert Wood Johnson Foundation (Policy for Action, Interdisciplinary Research Leaders, and Public Health Law Research). He has received honors such as the Early Career Award for Excellence from American Public Health Association. He was a postdoctoral researcher at the MIT, FDA Regulatory Science Fellow (jointly organized by the National Academy of Medicine), and CDC-National Center of Health Statistics Health Policy Fellow. He is a member of AcademyHealth Education Council. He holds graduate degrees in Public Health (Harvard), Health Policy (Harvard), and Law (Penn).

Dorit R. Reiss, PhD, is Professor of Law and the James Edgar Hervey '50 Chair of Litigation at UC Hastings Law, San Francisco. Her undergraduate degree in Law and Political Science (1999, Magna cum Laude) is from the Faculty of Law in the Hebrew University of Jerusalem where she served as Editor in Chief of the Law Review. Following graduation from law school, Professor Reiss clerked for a year and a half in the Israeli Ministry of Justice's Department ofPublic Law, working on a variety of constitutional and administrative law issues. She received her Ph.D. from the Jurisprudence and Social Policy program in UC Berkeley, writing her dissertation on accountability in the liberalized telecommunications and electricity sectors in England, France and Sweden. Since 2013, her research and activities are focused on legal and policy issues related to vaccines. She writes about school mandate, policy responses to non-vaccinating, tort issues and administrative issues related to vaccines.

作者簡介(中文翻譯)

Y. Tony Yang, ScD, LLM, MPH，是喬治華盛頓大學的健康政策終身教授，位於華盛頓特區。他的主要學術興趣在於法律與健康系統交匯處的政策問題，特別是在疫苗接種政策方面。他對大多數研究採取實證方法，將計量經濟學和統計科學的方法與更傳統的法律研究方法相結合。他已發表超過150篇經過同行評審的文章。他的第一作者作品出現在多個領先的期刊上，包括NEJM、JAMA、Lancet、Health Affairs和American Journal of Public Health。他的學術影響力在媒體報導中可見一斑，如CNN、NPR、NY Times、Washington Post和Wall Street Journal。他作為首席研究員獲得超過550萬美元的美國聯邦資助。此外，他還作為首席研究員獲得各種基金會的支持，包括羅伯特·伍德·約翰遜基金會（Policy for Action、Interdisciplinary Research Leaders和Public Health Law Research）。他曾獲得美國公共衛生協會的早期職業卓越獎。他曾在麻省理工學院擔任博士後研究員，並擔任FDA的監管科學研究員（由國家醫學院共同組織），以及CDC國家健康統計中心的健康政策研究員。他是AcademyHealth教育委員會的成員。他擁有哈佛大學的公共衛生（Harvard）、健康政策（Harvard）和法律（Penn）研究生學位。

Dorit R. Reiss, PhD，是舊金山UC Hastings法學院的法律教授及詹姆斯·埃德加·赫維'50訴訟主席。她的法學和政治學學士學位（1999年，優等生）來自耶路撒冷希伯來大學的法學院，並曾擔任法律評論的主編。法學院畢業後，Reiss教授在以色列司法部公共法部門擔任了一年半的法官助理，處理各種憲法和行政法問題。她在加州大學伯克利分校的法學與社會政策項目獲得博士學位，並撰寫了關於英國、法國和瑞典的電信和電力行業自由化問責制的論文。自2013年以來，她的研究和活動專注於與疫苗相關的法律和政策問題。她撰寫有關學校強制接種、對不接種疫苗的政策反應、侵權問題以及與疫苗相關的行政問題的文章。

類似商品